AGOSTINI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 479
EU - Europa 164
AS - Asia 98
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 4
Totale 749
Nazione #
US - Stati Uniti d'America 479
IT - Italia 55
IE - Irlanda 42
CN - Cina 40
SG - Singapore 37
SE - Svezia 32
FR - Francia 10
DE - Germania 9
IN - India 8
KR - Corea 6
EU - Europa 4
NG - Nigeria 4
BE - Belgio 3
FI - Finlandia 3
GB - Regno Unito 3
JP - Giappone 3
AT - Austria 2
CH - Svizzera 2
PK - Pakistan 2
SI - Slovenia 2
HK - Hong Kong 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 749
Città #
Chandler 162
Dublin 42
Ashburn 33
Singapore 29
Nyköping 24
Princeton 15
Fairfield 14
Hebei 13
Boston 12
Medford 11
Turin 11
Milan 9
Pune 8
Torino 8
Beijing 7
Hangzhou 7
Chengdu 6
New York 6
Santa Clara 6
Seoul 6
Abuja 4
Cambridge 4
Norwalk 4
Parma 4
Washington 4
Wilmington 4
Bari 3
Brussels 3
Castiglione Olona 3
Los Angeles 3
Redmond 3
Seattle 3
Woodbridge 3
Houston 2
Karachi 2
Lappeenranta 2
Ljubljana 2
London 2
L’Aquila 2
Perugia 2
Redwood City 2
San Diego 2
Schwerin 2
Cattolica 1
Clearwater 1
Denizli 1
Esslingen am Neckar 1
Fagnano Olona 1
Frederick 1
Genoa 1
Grugliasco 1
Guangzhou 1
Guiyang 1
Gunzenhausen 1
Hefei 1
Helsinki 1
Henderson 1
Kawasaki 1
Mountain View 1
Provo 1
Renens 1
Richmond 1
Shenyang 1
Stockholm 1
Stuttgart 1
Tokyo 1
Upper Marlboro 1
Totale 518
Nome #
Immunotherapy in Xeroderma Pigmentosum: A case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review 76
Immunotherapy in transplanted patients: A special population that can no longer be ignored 69
Lambert-Eaton Myasthenic Syndrome and Paraneoplastic Cerebellar Degeneration Associated with Merkel Cell Carcinoma with Unknown Primary: A Case Report 57
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era 56
Case Report: Atypical Cutaneous Presentation of Human T-cell Lymphotropic Virus Type 1-Related Adult T-cell Lymphoma 51
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study 50
Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit 46
Prognostic and predictive biomarkers in stage iii melanoma: Current insights and clinical implications 45
Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study 44
Tocilizumab and its usage for skin diseases 43
Ruta graveolens phytophotodermatìtis 42
Misuse, consequences and phototoxic skin-related effects of Rutaceae: a comprehensive literature review 41
Patients with psoriasis resistant to multiple biological therapies: characteristics and definition of a difficult-to-treat population 36
Eyelashes poliosis as first sign of metastatic melanoma 32
Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19 31
Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review 22
Perspectives of immunotherapy in non-melanoma skin cancers 17
Invasive SCC and Tirbanibulin: Experience in Patient With Epidermodysplasia Verruciformis 10
Primary cutaneous lymphoma patients seen at a referral dermatological centre in 1 year: A single-centre observational retrospective cohort study of the diagnoses and staging, comorbidities and associated symptoms, treatment performed and clinical course 9
Mixed purpuric and maculopapular eruption in a 70-year-old woman 5
Totale 782
Categoria #
all - tutte 4.051
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.051


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 0 2 4
2021/2022235 41 7 7 9 46 13 4 4 8 4 42 50
2022/2023346 31 50 6 31 41 68 17 20 38 11 22 11
2023/2024170 14 29 12 12 9 44 0 10 0 17 9 14
2024/202525 2 23 0 0 0 0 0 0 0 0 0 0
Totale 782